SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Lee TH) "

Sökning: WFRF:(Lee TH)

  • Resultat 1-50 av 610
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • 2021
  • swepub:Mat__t
  •  
3.
  • Aad, G, et al. (författare)
  • 2015
  • swepub:Mat__t
  •  
4.
  • Niemi, MEK, et al. (författare)
  • 2021
  • swepub:Mat__t
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  • Thomas, HS, et al. (författare)
  • 2019
  • swepub:Mat__t
  •  
9.
  • Kanai, M, et al. (författare)
  • 2023
  • swepub:Mat__t
  •  
10.
  •  
11.
  •  
12.
  • Ruilope, LM, et al. (författare)
  • Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
  • 2019
  • Ingår i: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 50:5, s. 345-356
  • Tidskriftsartikel (refereegranskat)abstract
    • <b><i>Background:</i></b> Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. <b><i>Patients and</i></b> <b><i>Methods:</i></b> The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate ≥25 mL/min/1.73 m<sup>2</sup> and albuminuria (urinary albumin-to-creatinine ratio ≥30 to ≤5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level α = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. <b><i>Conclusions:</i></b> FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049.
  •  
13.
  •  
14.
  •  
15.
  •  
16.
  •  
17.
  •  
18.
  •  
19.
  •  
20.
  •  
21.
  •  
22.
  •  
23.
  •  
24.
  •  
25.
  •  
26.
  •  
27.
  •  
28.
  •  
29.
  • Aad, G, et al. (författare)
  • Search for Higgs Boson Pair Production in the γγbb[over ¯] Final State Using pp Collision Data at sqrt[s]=8 TeV from the ATLAS Detector.
  • 2015
  • Ingår i: Physical Review Letters. - 1079-7114. ; 114:8
  • Tidskriftsartikel (refereegranskat)abstract
    • Searches are performed for resonant and nonresonant Higgs boson pair production in the γγbb[over ¯] final state using 20 fb^{-1} of proton-proton collisions at a center-of-mass energy of 8 TeV recorded with the ATLAS detector at the CERN Large Hadron Collider. A 95% confidence level upper limit on the cross section times branching ratio of nonresonant production is set at 2.2 pb, while the expected limit is 1.0 pb. The difference derives from a modest excess of events, corresponding to 2.4 standard deviations from the background-only hypothesis. The limit observed in the search for a narrow X→hh resonance ranges between 0.7 and 3.5 pb as a function of the resonance mass.
  •  
30.
  •  
31.
  •  
32.
  •  
33.
  •  
34.
  •  
35.
  •  
36.
  • Aaltonen, T., et al. (författare)
  • Combination of CDF and D0 measurements of the W boson helicity in top quark decays
  • 2012
  • Ingår i: Physical Review D. - 1550-7998 .- 1550-2368. ; 85:7, s. 071106-
  • Tidskriftsartikel (refereegranskat)abstract
    • We report the combination of recent measurements of the helicity of the W boson from top quark decay by the CDF and D0 collaborations, based on data samples corresponding to integrated luminosities of 2.7-5.4 fb(-1) of p (p) over bar collisions collected during Run II of the Fermilab Tevatron collider. Combining measurements that simultaneously determine the fractions of W bosons with longitudinal (f(0)) and right-handed (f(+)) helicities, we find f(0) = 0.722 +/- 0.081[+/- 0.062(stat) +/- 0.052(syst)] and f(+) = -0.033 +/- 0.046[+/- 0.034(stat) +/- 0.031(syst)]. Combining measurements where one of the helicity fractions is fixed to the value expected in the standard model, we find f(0) = 0.682 +/- 0.057[+/- 0.035(stat) +/- 0.046(syst)] for fixed f(+) and f(+) = -0.015 +/- 0.035[+/- 0.018(stat) +/- 0.030(syst)] for fixed f(0). The results are consistent with standard model expectations.
  •  
37.
  • Aaltonen, T., et al. (författare)
  • Combination of Tevatron Searches for the Standard Model Higgs Boson in the W+W- Decay Mode
  • 2010
  • Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 104:6, s. 061802-
  • Tidskriftsartikel (refereegranskat)abstract
    • We combine searches by the CDF and D0 Collaborations for a Higgs boson decaying to W+W-. The data correspond to an integrated total luminosity of 4.8 (CDF) and 5.4 (D0) fb(-1) of p (p) over bar collisions at root s = 1.96 TeV at the Fermilab Tevatron collider. No excess is observed above background expectation, and resulting limits on Higgs boson production exclude a standard model Higgs boson in the mass range 162-166 GeV at the 95% C.L.
  •  
38.
  • Aaltonen, T., et al. (författare)
  • Evidence for a Particle Produced in Association with Weak Bosons and Decaying to a Bottom-Antibottom Quark Pair in Higgs Boson Searches at the Tevatron
  • 2012
  • Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 109:7, s. 071804-
  • Tidskriftsartikel (refereegranskat)abstract
    • We combine searches by the CDF and D0 Collaborations for the associated production of a Higgs boson with a W or Z boson and subsequent decay of the Higgs boson to a bottom-antibottom quark pair. The data, originating from Fermilab Tevatron p (p) over bar collisions at root s = 1.96 TeV, correspond to integrated luminosities of up to 9.7 fb(-1). The searches are conducted for a Higgs boson with mass in the range 100-150 GeV/c(2). We observe an excess of events in the data compared with the background predictions, which is most significant in the mass range between 120 and 135 GeV/c(2). The largest local significance is 3.3 standard deviations, corresponding to a global significance of 3.1 standard deviations. We interpret this as evidence for the presence of a new particle consistent with the standard model Higgs boson, which is produced in association with a weak vector boson and decays to a bottom-antibottom quark pair.
  •  
39.
  •  
40.
  • Aad, G., et al. (författare)
  • 2014
  • Tidskriftsartikel (refereegranskat)
  •  
41.
  • Aad, G., et al. (författare)
  • 2014
  • Ingår i: Physical Review C (Nuclear Physics). - 0556-2813 .- 1089-490X. ; 90:4
  • Tidskriftsartikel (refereegranskat)
  •  
42.
  • Aad, G., et al. (författare)
  • 2014
  • Ingår i: The European Physical Journal C. - : Springer Science and Business Media LLC. - 1434-6052. ; 74:8
  • Tidskriftsartikel (refereegranskat)
  •  
43.
  • Aad, G., et al. (författare)
  • 2015
  • Tidskriftsartikel (refereegranskat)
  •  
44.
  • Aad, G., et al. (författare)
  • 2015
  • Tidskriftsartikel (refereegranskat)
  •  
45.
  • Aad, G., et al. (författare)
  • 2014
  • Tidskriftsartikel (refereegranskat)
  •  
46.
  • Aad, G., et al. (författare)
  • 2014
  • Ingår i: The European Physical Journal C. - : Springer Science and Business Media LLC. - 1434-6052. ; 74:6
  • Tidskriftsartikel (refereegranskat)
  •  
47.
  • Aad, G., et al. (författare)
  • 2014
  • Tidskriftsartikel (refereegranskat)
  •  
48.
  • Aad, G., et al. (författare)
  • 2014
  • Ingår i: The European Physical Journal C. - : Springer Science and Business Media LLC. - 1434-6052. ; 74:10
  • Tidskriftsartikel (refereegranskat)
  •  
49.
  • Aad, G., et al. (författare)
  • 2014
  • Tidskriftsartikel (refereegranskat)
  •  
50.
  • Aad, G., et al. (författare)
  • 2014
  • Tidskriftsartikel (refereegranskat)
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-50 av 610
Typ av publikation
tidskriftsartikel (487)
forskningsöversikt (3)
konferensbidrag (2)
Typ av innehåll
refereegranskat (596)
övrigt vetenskapligt/konstnärligt (9)
Författare/redaktör
Liu, Y. (469)
Oh, S. H. (467)
Meyer, J. (463)
Mehta, A. (459)
Chen, X. (458)
Clark, A. (458)
visa fler...
Price, D. (458)
Fox, H. (457)
Li, H. (457)
Quadt, A. (457)
Robson, A. (456)
Gorelov, I. (455)
Hou, S. (455)
Hubacek, Z. (455)
Kehoe, R. (455)
Kroll, J. (455)
Kupco, A. (455)
Lipeles, E. (455)
Lokajicek, M. (455)
Neal, H. A. (455)
Sawyer, L. (455)
Abbott, B. (454)
Bocci, A. (454)
Brandt, A. (454)
Burdin, S. (454)
Campanelli, M. (454)
Cerri, A. (454)
Cerrito, L. (454)
Cooke, M. (454)
D'Onofrio, M. (454)
Errede, S. (454)
Evans, H. (454)
Fiedler, F. (454)
Giokaris, N. (454)
Khanov, A. (454)
Kim, S. H. (454)
Loginov, A. (454)
Pleier, M. -A. (454)
Qian, J. (454)
Simak, V. (454)
Annovi, A. (453)
Borissov, G. (453)
Boudreau, J. (453)
Brock, R. (453)
Giagu, S. (453)
Hohlfeld, M. (453)
Jones, G. (453)
Limosani, A. (453)
Seifert, F. (453)
Shabalina, E. (453)
visa färre...
Lärosäte
Lunds universitet (363)
Uppsala universitet (336)
Stockholms universitet (304)
Kungliga Tekniska Högskolan (297)
Karolinska Institutet (120)
Göteborgs universitet (25)
visa fler...
Umeå universitet (20)
Högskolan Dalarna (8)
Örebro universitet (7)
Chalmers tekniska högskola (6)
Högskolan i Skövde (5)
Linköpings universitet (4)
Högskolan Kristianstad (1)
Jönköping University (1)
Handelshögskolan i Stockholm (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (610)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (358)
Medicin och hälsovetenskap (70)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy